Quick facts Flashcards
Re: Providone/Iodine as an antispectic/disinfectant - what are its main action, onset/duration, advantages & limitations and spectrum of activity?
Main action: Oxidative damage.
Onset/Duration: Onset: Iodine is bacteriocidal in 1 minute and kills spores in 15 minutes. However in povidine compounding it has a delayed onset/Duration: No sustained effect
Advantages:
1. Sporicidal
2. Cheap
3. Broad spectrum
Most effective for intact skin
Limitations:
1. Hypersensitivity reactions
2. Delayed onset without residual activity
3. Stains clothes and dressings
Spectrum of activity:
- Bacteria (G+ve and –ve and acid fast)
- Sporicidal
- Viruses
- Fungi
Ineffective against:
Prions
Hydrophilic viruses
Other:
Can be used as antiseptics or disinfectants (latter contains more iodine)
4 types of lung receptors (peripheral afferents)
Respiratory
- Pulmonary stretch receptors - discharge in response to distension of lung & activity is sustained with lung inflation - ie. They show little adaptation
- Irritant receptors - Rapidly respond to airway irritants - eg. Cigarette smoke/noxious gases/cold air
- J receptors - respond to chemicals injected into the pulmonary circulation –> results in rapid, shallow breathing
- Bronchial C fibres - respond to chemical injected into the bronchial circulation –> results in rapid, shallow breathing
Hering-Bruer reflex
Respiratory
Stimulation of pulmonary stretch receptors results in slowing of respiration due to increase in expiratory time
[Opposite is true for expiration]
Normal compliance
Respiratory
100mL/cmH2O
* C(lung)= 200mL/cmH2O; C(chest wall) = 200mL/cmH2O
Specific compliance = 0.05/cmH2O
Malignant hyperthermia incidence
Pharmacogenetics
1:5,000 - 1:50,000
What is porphyria?
Pharmacogenetics
Mutation of haem synthesis enzymes which causes a build-up of neurotoxic intermediate metabolites (porphyrin precursors) in response to various drugs (anticonvulsants, antibiotics, thiopentone)
○ Autosomal dominant
Malignant hyperthermia mechanism
Pharmacogenetics
Mutation of the ryanodine calcium channel receptor which causes a hypermetabolic crisis in response to volatile anaesthetics
Malignant hyperthermia signs/symptoms
Pharmacogenetics
○ Initial - tachycardia, masseter spasm, hypercapnoea, arrhythmia
○ Intermediate - hyperthermia, sweating, combined metabolic and respiratory acidosis, hyperkalaemia, muscle rigidity
○ Late - rhabdomyolosis, coagulopathy, cardiac arrest
Malignant hyperthermia Mx
Pharmacogenetics
Cease volatile, start TIVA, give dantrolene 2.5mg/kg increments to 10mg/kg, Rx of complications
Atypical plasma cholinesterase/pseudocholinesterase
Congenital/acquired/both/neither?
Pharmacogenetics
Fails to metabolise suxamethonium and causes “sux apnoea”
○ Congenital - autosomal recessive
○ Acquired - due to loss of plasma cholinesterase. Can occur in pregnancy, organ failure (hepatic, renal, cardiac), malnutrition, hyperthyroidism, burns, malignancy, drugs (OCP, ketamine, lignocaine and ester Las, metoclopramide, lithium)
○ Note: acquired disease will have normal dibucaine no but just decreased quantity of enzyme
How to test for atypical plasma cholinesterase/pseudocholinesterase?
Pharmacogenetics
○ Measured by dibucaine number. Dibucaine is an amide LA, which inhibits plasma cholinesterase. Greater inhibition indicates a less severe mutation - so normal:normal dibucaine no = 80 (80% inhibited). Dibucaine resistant:resistant has a no of 20 (20% inhibited)
G6PD deficiency
Pharmacogenetics
Mutation of glucose 6-phosphate dehydrogenase which produces acute haemolysis in response to oxidative stress due to dapsone, methylene blue, fluoroquinolones, antimalarialas and rasburicase
Normal cardiac output and cardiac index values
CO = 5L/min; CI = 2.5-4L/min
LaPlace’s Law (cardiac)
sigma = Pr/2h
where sigma = myocardial wall stress
P = transmural pressure
r = radius
h = ventricular wall thickness
Features of SA node and ventricular myocyte action potentials: resting, threshold, peak potentials
Ventricular myocyte:
* Resting potential: -90mV
* Threshold: -70mV
* Peak: +50mV
SA node:
* Max diastolic (nil real resting potential): -70mV
* Threshold: -40mV
* Peak: +20mV
Structure of fast cardiac Na+ channel
2xβ subunits
1x α subunit
* Has 4 domains - I-IV
* The N- & C- terminus are both intracellular
* Each domain has 6 transmembrane segments linked by intracellular and extracellular peptides
–Extracellular peptides linking segments 5-6 form the ion pore (responsible for ion selectivity - the Ca channel has similar structure but is Ca selective)
–Domain IV undergoes a conformational change in response to voltage & opens the pores (activation gate - ‘m’)
– The intracellular peptide loop connecting domain III & IV forms the inactivation gate ‘h’
What membrane potential does the absolute refractory period of a cardiac action potential go up to?
Absolute refractory period is up to ~-50mV. At this value, some fast Na+ channels have recovered from inactivation enough to permit response to stimulation
Time constant equation
(tau) = compliance x resistance
What are the functions of the FRC?
- Oxygen reservoir - prevents rapid changes in alveolar oxygen tension and arterial oxygen content by maintaining gas exchange throughout expiration
- Maintenance of small airway patency (N2 splinting)
- Optimising respiratory workload - compliance maximal at FRC, WOB required from FRC is minimal
○ Keeps tidal volume over steep part of lung compliance curve - Minimises pulmonary vascular resistance & hence RV afterload/work/oxygen demand
What are the factors affecting FRC
Normal WOB
0.35J/L
Oxygen requirement of breathing
The oxygen requirement of breathing at rest is 2-5% of VO2 or 3ml/min
(tidal breathing uses <2% of BMR)
Normal osmolarity
~285mOsm/kg
Baroreceptor reflex
- Sensor/stimulus: carotid sinus & aortic arch - circumferential and longitudinal stretch receptors detect change in BP
○ Decreased BP decreases firing rate of baroreceptor- Afferent: glossopharyngeal + vagus
- Processor: NTS & Caudal ventral medulla/RVLM
○ Decreased BR firing rate –> decreases GABA secretion from caudal VM. This decreases inhibition of sympathetic output from RVLM (ie SNS activity increased) - Efferent/effectors: vagus nerve + sympathetic chain
○ Peripheral vessels - a1 mediated vasoconstriction
○ Decreased vagal input into SA - Effect: increased HR and BP in response to fall in BP
- Note: Tends to override Bainbridge reflex when it comes to atrial stretch in hypovolaemia (except in spinal anaesthesia, where reverse Bainbridge reflex may predominate)
Bainbridge reflex
- Sensor/stimulus: Stretch receptors in atria + pulmonary artery measure changes in pressure
- Afferent: vagus
- Processor: NTS & CVM
- Efferent:
○ Sympathetic fibres to heart
○ Vagal efferents to gardiac ganglion - Effects
○ Increased RA pressure produces an increase heart rate
Chemoreceptor reflex
- Sensor/stimulus: Carotid and aortic body detect low PaO2 and/or high PaCO2
- Afferent: glossopharyngeal + vagus
- Processor: NTS + Nucleus ambiguus
- Efferents/effectors:
○ Sympathetic fibres to heart and peripheral smooth muscle
○ Vagal efferents to cardiac ganglion - Effects:
○ Primary effects - bradycardia, hypertension
○ Secondary effects - increased preload due to increased ventilation, thus activation of Bainbridge –> increased heart rate
○ Activation of pulmonary stretch receptors –> activation of Hering-Breuer reflex –> increases HR
Cushing reflex
- Sensor/stimulus: intracranial pressure/cerebral ischaemia is detected by some unknown sensor
- Afferent:
○ Fibres from the medullary mechanosensory areas, to sympathetic ganglia
○ Fibres from cerebral hemispheres, which exert descending inhibitory control on the medullary vasomotor sensor - Processor: rostral ventrolateral medulla
- Efferents/effectors: Sympathetic fibres to heart and peripheral smooth muscle
- Effects:
○ Hypertension + tachycardia
○ Secondary - baroreflex mediated bradycardia
- Afferent:
Bezold-Jarisch Reflex
- Sensor/stimulus: Multiple and heterogeneous stimuli interact with receptors in all cardiac chambers, including:
○ Mechanical: pressure and stretch (thus, inotropy preload and afterload)
○ Chemical: veratrum alkaloids, ATP, capsaicin, snake venom, other venoms- Afferent: unmyelinated C-fibres of vagus
- Processor: NTS
- Efferents/effectors: sympathetic fibres to heart and peripheral smooth muscle, vagus via cardiac ganglion
- Effects: hypotension (vasodilation) & bradycardia
Occulocardic reflex
- Sensor/stimulus: mechanoreceptors on the globe and in facial muscles detect pressure on the globe
- Afferent: long and short ciliary nerves to trigeminal nerve (via Gasserian ganglion) to sensory nucleus of TN. From here, short internuclear fibres to NTS
- Processor: NTS
- Efferents/effectors: vagus nerve via cardiac ganglion to SA + AV node
- Effects: bradycardia, if severe, to the point of arrest
Diving reflex
- Sensor/stimulus: pain, temperature, chemical and mechanosensitive stretch receptors detect pressure to globe of eye, pain in trigeminal nerve distribution, cold temperature, or noxious stimulus of anterior ethmoidal nerve
- Afferent: trigeminal nerve
- Processor: NTS (vagal response), Rostral medulla (sympathetic response), ventral response (apnoea)
- Efferents/effectors: Vagus nerve via cardiac ganglion to SA, AV nodes; phrenic nerve to respiratory muscles
- Effects: bradycardia, cerebral vasodilation + systemic vasoconstriction, apnoea
○ Net effect is to prevent aspiration and maximise blood flow to CNS at the expense of skin, muscle and splanchnic organs
Barcroft-Edholm Reflex
- Sensor/stimulus: Emotional distress/orthostatic changes, increased ITP (eg. Defecation, cough/sneeze, laughter)
- Afferent: unknown
- Processor: ?NTS/Nucleus ambiguus
- Efferents/effectors: vagus & SNS to SA, AV nodes, peripheral smooth muscle
- Effects: Vagal - bradycardia, sympathetic - systemic vasodilation
SvO2 from tissue beds: jugular, muscles, renal, IVC, SVC, Hepatic
Jugular - 55%
Muscles - 72%
Renal - 81%
IVC - 71%
SVC - 79%
Hepatic - 66%
Normal mixed venous PO2 & SvO2
40mmHg & 70-75%
Energy consumption of 1 MET
1 MET = 3.5 ml O2/kg/minute
Aortocaval compression syndrome
- Seen as early as wk 20
- Compression of IVC by gravid uterus - decreases venous return & reduced CO
* Blood returns to heart via paravertebral epidural veins draining into azygous
* Uterine perfusion diminished secondary to increased uterine venous pressure - Compression of aorta may be present & associated with uterine arterial hypotension + reduced uteroplacental perfusion
- Can be relieved by positioning mother to left side
Changes in afterload during pregnancy
Afterload (reduced) –> TPR decreases by 30% by wk 12& 35% (by week 20th wk, then remains at 30% below non-pregnant values)
* Vasodilation mediated by progesterone, prostaglandins & downregulation of alpha-receptors
* SBP + DBP - decrease (~10%) & reach nadir at 20wks
* Vascular system as whole becomes more refractory to vasoconstrictors
* Note re: RV afterload
□ CVP + PCWP - remain stable throughout pregnancy. PCWP balance by decreased PVR
Changes in preload during pregnancy
○ Preload (increased) –> By term, maternal blood volume increased by 35-40% (approx 1-1.5L)
§ Plasma volume increases by 45% - Na + H2O retention by oestrogen stimulation of RAAS
§ RBC volume increases by 20% due to renal erythropoietin synthesis
§ Disproportionate rise in plasma volume vs red cell mass accounts for fall of haematocrit to 33% (“anaemia of pregnancy”)
Changes in CO, HR and SV during pregnancy
CO increases by 40-45% by 12-28wks, peaks at 50% 32-36wks, then reaches 47% at term
- Heart rate: HR increases by 17% at end of first trimester,(increases to 25% at middle of third trimester);
- Stroke volume increases by 20-30% (predom in 1st trim)
Changes to distribution of CO in pregnancy (regional flow changes)
- Distribution (regional flow changes)
○ Renal blood flow - increases by 80% in first trimester (may fall slightly towards term)
○ Large proportion of blood flow is directed to uteroplacental circulation, that increases its blood flow 10-fold to 750mL/min at term
○ Increased blood flow to breasts, GIT, skin
Physical and mechanical changes to heart during pregnancy
Physical/mechanical changes:
- LV mass increases by 40g by 3rd trimester
- Heart is more rotated to left
○ May see Q waves + TWI in inferior leads
- Colloid oncotic pressure falls by 14% - may predispose to oedema
CVS changes during PARTUITION + Post delivery:
- Pressure:
○ Maternal SBP + DBP increase 10-20mmHg during uterine contraction- Volume:
○ Each uterine contraction squeezes ~300mL blood from uterus into central maternal circulation - Cardiac output:
○ CO increases by ~15% during latent phase of labour, by 30% during the active phase & 45% during the expulsive stage
○ Immediately after delivery, CO ~60-80% above pre-labour values as a consequence of autotransfusion & increase venous return associated with uterine involution - CO & SBP/DBP return to non-pregnant values by 2 wks post delivery
- Volume:
How long after birth do pregnancy-induced respiratory changes settle?
After birth:
* FRC and RV return to normal within 48h
* Vt returns to normal within 5 days
Effect of pregnancy on lung mechanics
- Compliance
○ increased adipose tissue and breast mass –> decreased chest wall compliance (lung compliance unchanged)- Resistance
○ Increases in early pregnancy - mucosal oedema
○ Progesterone-mediated bronchodilation - decreased resistance in later pregnancy (35%)
- Resistance
Storage functions of the liver
- Storage
- Metabolic fuel: Glycogen- ~100g & fat
- Fat soluble vitamins
○ Vitamin A → stored in stellate cells –> converted to retinol (active form). Contains 1-2yr supply
○ Vitamin D → ~ 1-4 month supply
○ Vitamin E & vitamin K - minimal - Vitamin B12 + folate (50% of body’s storage for both)
- Trace elements - iron (as ferritin), zinc, copper, selenium
- Blood reservoir - ~ 500mL of blood
Synthetic functins of the liver
Synthetic
- Plasma proteins- albumin, α+ β globulins, fibrinogen
- Nutrients - glucose, ketones, lipids, cholesterol, amino acids
- Regulatory molecules (thrombopoetin, angiotensinogen)
- Bile acids → stored in gallbladder